PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Pathology and Translational Medicine10.4132/jptm.2021.05.102021554279-288Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinomaTripti Nakra, Varsha Singh, Aruna Nambirajan, Prabhat Singh Malik, Anant Mohan, Deepali Jainhttp://www.jpatholtm.org/upload/pdf/jptm-2021-05-10.pdf, http://www.jpatholtm.org/journal/view.php?doi=10.4132/jptm.2021.05.10, http://www.jpatholtm.org/upload/pdf/jptm-2021-05-10.pdf
Journal of Thoracic Oncology10.1016/j.jtho.2018.08.130920181310S765-S766P2.09-12 EGFR Mutation Status in Squamous Cell Carcinoma or Non-Small Cell Carcinoma Favor Squamous Cell Carcinoma Diagnosed from Small Lung BiopsiesH. Ho, H. Kao, T. Chouhttps://api.elsevier.com/content/article/PII:S1556086418322676?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1556086418322676?httpAccept=text/plain
Diagnostic Pathology10.1186/s13000-019-0840-22019141The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsiesHsiang-Ling Ho, Hua-Lin Kao, Yi-Chen Yeh, Teh-Ying Chouhttp://link.springer.com/content/pdf/10.1186/s13000-019-0840-2.pdf, http://link.springer.com/article/10.1186/s13000-019-0840-2/fulltext.html, http://link.springer.com/content/pdf/10.1186/s13000-019-0840-2.pdf
Clinica Chimica Acta10.1016/j.cca.2015.01.039201544481-85EGFR T790M resistance mutation in non small-cell lung carcinomaMarc G. Denis, Audrey Vallée, Sandrine Théoleyrehttps://api.elsevier.com/content/article/PII:S0009898115000637?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0009898115000637?httpAccept=text/plain
Journal of Thoracic Oncology10.1097/jto.0b013e3181c6ed9b201054436-441Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation AnalysisAndrew G. Nicholson, David Gonzalez, Pallav Shah, Matthew J. Pynegar, Manjiri Deshmukh, Alexandra Rice, Sanjay Popathttps://api.elsevier.com/content/article/PII:S1556086415300952?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1556086415300952?httpAccept=text/plain
Open Medicine10.1515/med-2016-0014201611168-77Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinomaYuli Wang, Zhitao Guo, Yang Li, Qinghua Zhouhttps://www.degruyter.com/view/journals/med/11/1/article-p68.xml, https://www.degruyter.com/document/doi/10.1515/med-2016-0014/pdf
Lung Cancer10.1016/j.lungcan.2008.06.0212009633315-321Impact of EGFR mutation analysis in non-small cell lung cancerHiromasa Yamamoto, Shinichi Toyooka, Tetsuya Mitsudomihttps://api.elsevier.com/content/article/PII:S0169500208003632?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500208003632?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(20)30130-62020139S44Afatinib in EGFR mutant non-small-cell carcinoma: Milton Keynes experienceS.A. Rizvi, M. Karinahttps://api.elsevier.com/content/article/PII:S0169500220301306?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500220301306?httpAccept=text/plain
Reactions Weekly10.1007/s40278-018-51199-y201817171129-129Erlotinibhttp://link.springer.com/content/pdf/10.1007/s40278-018-51199-y.pdf, http://link.springer.com/article/10.1007/s40278-018-51199-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-51199-y.pdf
Lung Cancer10.1016/s0169-5002(16)30077-0201691S2260 Afatinib in EGFR mutation positive advanced non-small cell lung cancerR.S. Davies, A.E. Brewster, M.R. Button, J.F. Lesterhttps://api.elsevier.com/content/article/PII:S0169500216300770?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500216300770?httpAccept=text/plain